The PE Ratio as of December 2025 (TTM) for Advagene Biopharma Co., Ltd. (6709.TWO) is -23.02

According to Advagene Biopharma Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -23.02. This represents a change of 174.01% compared to the average of -8.40 of the last 4 quarters.

Advagene Biopharma Co., Ltd. (6709.TWO) Historical PE Ratio (quarterly & annually)

How has 6709.TWO PE Ratio performed in the past?

The mean historical PE Ratio of Advagene Biopharma Co., Ltd. over the last ten years is -16.38. The current -23.02 PE Ratio has changed 13.96% with respect to the historical average. Over the past ten years (40 quarters), 6709.TWO's PE Ratio was at its highest in in the June 2019 quarter at -4.64. The PE Ratio was at its lowest in in the June 2021 quarter at -14.54.

Advagene Biopharma Co., Ltd. (6709.TWO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Advagene Biopharma Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Advagene Biopharma Co., Ltd. (6709.TWO) Average PE Ratio

How has 6709.TWO PE Ratio performed in the past?

The current PE Ratio of Advagene Biopharma Co., Ltd. (6709.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Advagene Biopharma Co., Ltd. (6709.TWO) PE Ratio vs. Peers

How is 6709.TWO’s PE Ratio compared to its peers?

Advagene Biopharma Co., Ltd.’s PE Ratio is less than Chunghwa Chemical Synthesis & Biotech Co., Ltd. (-13.54), less than Genomics BioSci & Tech. Co.,Ltd. (-10.49), less than Sunny Pharmtech Inc. (-7.70), less than Greenyn Biotechnology Co., Ltd (14.08), less than Meribank Biotech Co., Ltd (-21.59), less than Hcmed (-16.45), less than InnoPharmax Inc. (-18.28), greater than Shangya Technology Co., Ltd. (-27.70), less than Enimmune corporation (-7.23), less than NaviFUS Corp. (-12.09),

Build a custom stock screener for Advagene Biopharma Co., Ltd. (6709.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Advagene Biopharma Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Advagene Biopharma Co., Ltd. (6709.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Advagene Biopharma Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.